8-K: Insperity Announces Disappointing First Quarter Results and Updated 2025 Guidance

Insperity reports lower than expected Q1 results due to higher healthcare costs and provides updated, lowered guidance for 2025.

Summary

• Insperity announced its first quarter results for 2025, revealing a 1% increase in average worksite employees (WSEEs) and a 3% increase in revenues year-over-year.
• Q1 net income was $51 million, with an adjusted EBITDA of $102 million.
• Diluted EPS was reported at $1.35, while adjusted EPS reached $1.57.
• The company returned $42 million to shareholders through share repurchases and cash dividends.
• Gross profit decreased by 10% to $310 million due to higher-than-expected benefits costs.
• Operating expenses increased by 2% to $242 million, including expenses related to the Workday strategic partnership.
• Insperity has updated its 2025 guidance, projecting average WSEEs paid between 308,800 and 316,400, and adjusted EPS between $2.23 and $3.28.
• Adjusted EBITDA for the full year is now expected to be between $190 million and $245 million.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the disappointing Q1 results, lowered guidance, and concerns about rising healthcare costs. While the Workday partnership is a positive, the near-term outlook is challenging.

Positives

• Revenues increased by 3% to $1.9 billion.
• The average number of worksite employees (WSEEs) paid per month increased 1% from Q1 2024.
• The company is making progress on its Workday strategic partnership, expecting it to drive growth in 2026 and beyond.
• Insperity returned $42 million to shareholders through share repurchases and dividends.

Negatives

• Gross profit decreased by 10% due to higher-than-expected benefits costs.
• Net income decreased by 35% to $51 million.
• Adjusted EBITDA decreased to $102 million.
• The company lowered its full-year 2025 guidance for adjusted EPS and adjusted EBITDA.
• Healthcare costs were significantly higher due to increased inpatient, outpatient, and pharmacy costs, as well as more frequent large claim activity.

Risks

• Adverse economic conditions could impact Insperity's performance.
• Failure to comply with client expectations regarding COVID-19 relief programs poses a risk.
• Labor shortages and increasing competition for skilled workers could affect operations.
• Inflation could impact costs and profitability.
• Increases in health insurance costs and workers compensation rates could negatively affect financial results.
• Disruptions of information technology systems or failure to enhance service and technology offerings could harm the business.
• The company's ability to fully realize the anticipated benefits of its strategic partnership with Workday, Inc. is uncertain.

Future Outlook

Insperity has updated its 2025 guidance, projecting average WSEEs paid between 308,800 and 316,400, adjusted EPS between $2.23 and $3.28, and adjusted EBITDA between $190 million and $245 million.

Management Comments

• Paul J. Sarvadi, Insperity chairman and chief executive officer, stated that the first quarter financial results reflect macro-economic turbulence and healthcare cost volatility but that the company is executing its game plan for future growth acceleration.
• James D. Allison, executive vice president of finance, chief financial officer and treasurer, mentioned that the company has initiated a pricing plan to address the projected higher healthcare cost trend and is evaluating other options to contain or reduce costs and drive improved profitability in 2026.

Industry Context

The PEO industry is facing increasing healthcare costs and economic uncertainty, which is impacting Insperity's financial performance. The company's strategic partnership with Workday is aimed at differentiating itself and driving future growth in a competitive market.

Comparison to Industry Standards

• Comparing Insperity's performance to peers like ADP or TriNet is difficult without their specific Q1 results, but the healthcare cost pressures are likely impacting the entire industry.
• Insperity's adjusted EBITDA margin of approximately 5.5% ($102 million/$1.863 billion) is a key metric to watch against industry benchmarks.
• The success of the Workday partnership will be crucial for Insperity to maintain a competitive edge against companies investing heavily in technology and HR solutions.

Stakeholder Impact

• Shareholders will be impacted by the lower earnings and reduced guidance.
• Employees may be affected by cost-cutting measures.
• Clients could see price increases to offset higher healthcare costs.
• Suppliers and creditors may experience changes in payment terms or volumes.

Next Steps

• Insperity will host a conference call to discuss the results and guidance.
• The company will focus on operating expense management and accelerating growth.
• Insperity will implement a pricing plan to address higher healthcare costs.
• The company will continue to develop its Workday strategic partnership.

Key Dates

Keywords

Insperity, WSEE, EBITDA, EPS, Human Resources, Financial Results, Guidance, Healthcare Costs